Watchdog OKs acquisitions of 100 percent of Bokamoso Private Hospital’s shares and capital
Botswana’s Competition Authority has approved Khella’s proposed acquisition of all issued shares in Bokamoso Private Hospital, and Kalend’s proposed acquisition of all issued share capital in the Hospital. Khella is a wholly owned subsidiary of Botswana Public Officers Medical Aid Scheme (BPOMAS). Kalend is a joint venture between BPOMAS and LenMed Health Plan.
Although the merged entity will have a market share of 35 percent post-transaction, the Competition Authority found that potential abuse of dominance would be held in check by an unchanged market structure.
Full content: Botswana Gazette
Related content: Competition Law Develops in Southern Africa (Heather Irvine & Candice Upfold, Norton Rose)
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI